Screening for neurofilament inclusion disease using alpha-internexin immunohistochemistry.
Uchikado
Hirotake
H
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Shaw
Gerry
G
Wang
Deng-Shun
DS
Dickson
Dennis W
DW
D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000175:diagnosis / Q000378:metabolism; D001921:Brain / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D002352:Carrier Proteins / Q000032:analysis / Q000378:metabolism*; D003704:Dementia / Q000175:diagnosis / Q000378:metabolism; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D002479:Inclusion Bodies / Q000378:metabolism / Q000473:pathology*; D007381:Intermediate Filament Proteins; D007382:Intermediate Filaments / Q000378:metabolism / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D019578:Multiple System Atrophy / Q000175:diagnosis / Q000378:metabolism; D019636:Neurodegenerative Diseases / Q000175:diagnosis* / Q000378:metabolism / Q000503:physiopathology; D009474:Neurons / Q000378:metabolism / Q000473:pathology*; D020734:Parkinsonian Disorders / Q000175:diagnosis / Q000378:metabolism; D011237:Predictive Value of Tests; D011712:Pyramidal Tracts / Q000378:metabolism / Q000473:pathology; D024801:Tauopathies / Q000175:diagnosis / Q000378:metabolism
D002352:Carrier Proteins; D007381:Intermediate Filament Proteins; C046643:alpha-internexin